As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Featured article: Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series
Crohn’s disease (CD) is rising in incidence and has a high morbidity and increased mortality. It has been shown that there is an imbalance present in the gut microbiome (dysbiosis) in CD with a possible infective aetiology—Mycobacterium avium subsp. paratuberculosis (MAP) being the most proposed. The objective of this study was to report on the treatment and clinical outcomes of patients with CD in prolonged remission.
Gut Pathogens celebrates its 10th anniversary
Gut Pathogens launched in 2009 and its growth has followed the fast-paced developments of the field in the last ten years, from probiotics to bacterial genomics, to the rise of microbiome research. Dr. Niyaz Ahmed, Editor-in-Chief, tells us more about the success stories.
We also look back on just some of the high quality work published by Gut Pathogens as we look forward to the next ten years
Articles
-
-
Development of a highly effective low-cost vaporized hydrogen peroxide-based method for disinfection of personal protective equipment for their selective reuse during pandemics
-
Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in Bacteroides fragilis strains isolated from patients diagnosed with colorectal cancer
-
A novel 5-Plex qPCR-HRM assay detecting human diarrheal parasites
-
Clostridioides difficile ribotype distribution in a large teaching hospital in Serbia
-
Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?
-
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II – contemporary contextual research
-
A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome
-
Characterization of the cytolethal distending toxin (typhoid toxin) in non-typhoidal Salmonella serovars
-
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part I – autointoxication revisited
Blogs
Failed to load RSS feed.
Editor-in-Chief
Niyaz Ahmed, University of Hyderabad, India
Call for papers: cross-journal series
Aims and scope
Gut Pathogens publishes research on both biological and clinical aspects of the pathogens, commensals and functional microbiota of the gut, including probiotic bacteria and yeasts and their products. The journal also considers timely reports on the novel aspects of genomics, metagenomics, microbiota profiling and systems biology, as well as studies identifying new genome sequences of gut microbes.
Follow
Annual Journal Metrics
-
Speed
49 days to first decision for reviewed manuscripts only
29 days to first decision for all manuscripts
112 days from submission to acceptance
14 days from acceptance to publication
Citation Impact
3.169 - 2-year Impact Factor
3.522 - 5-year Impact Factor
0.987 - Source Normalized Impact per Paper (SNIP)
1.183 - SCImago Journal Rank (SJR)
Usage
260,469 Downloads
270 Altmetric Mentions
